News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioVigilant Systems Inc. Submits Drug Master Files to FDA, Accelerating Regulatory Approval Process for Instantaneous Microbial Detection Equipment Use



10/7/2008 9:00:04 AM

TUCSON, Ariz.--(BUSINESS WIRE)--BioVigilant Systems, Inc. (www.biovigilant.com), inventors of Instantaneous Microbial Detection, today announced that the Company has submitted two Type V Drug Master Files (DMFs) to the U.S. Food and Drug Administration (FDA) for its IMD(TM)-A product line, a family of products used for rapid environmental air monitoring in pharmaceutical environments. In support of customers’ filings, these DMFs may now be referenced by pharmaceutical drug manufacturers who wish to use BioVigilant’s systems in FDA-regulated applications.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES